1D0G | R:62-101; T:62-101; R:21-61; S:21-61; T:21-61; S:102-130; T:102-130; R:102-128; S:62-101 | CRYSTAL STRUCTURE OF DEATH RECEPTOR 5 (DR5) BOUND TO APO2L/TRAIL |
1D4V | A:115-154; A:69-114; A:155-185 | CRYSTAL STRUCTURE OF TRAIL-DR5 COMPLEX |
1DU3 | A:62-101; A:21-61; B:21-61; C:21-61; G:21-61; H:21-61; I:21-61; B:62-101; C:62-101; B:102-130; G:102-128; G:62-101; H:62-101; I:62-101 | CRYSTAL STRUCTURE OF TRAIL-SDR5 |
1EXT | A:98-148; B:11-97; B:98-148; A:13-97 | EXTRACELLULAR DOMAIN OF THE 55KDA TUMOR NECROSIS FACTOR RECEPTOR. CRYSTALLIZED AT PH3.7 IN P 21 21 21. |
1FT4 | A:98-150; B:14-97; A:11-97; B:98-150 | PHOTOCHEMICALLY-ENHANCED BINDING OF SMALL MOLECULES TO THE TUMOR NECROSIS FACTOR RECEPTOR-1 |
1NCF | A:98-150; B:14-97; A:11-97; B:98-150 | A NEW PARADIGM FOR TUMOR NECROSIS FACTOR SIGNALLING |
1OSX | A:17-42 | SOLUTION STRUCTURE OF THE EXTRACELLULAR DOMAIN OF BLYS RECEPTOR 3 (BR3) |
1SG1 | X:83-161; X:2-82 | CRYSTAL STRUCTURE OF THE RECEPTOR-LIGAND COMPLEX BETWEEN NERVE GROWTH FACTOR AND THE COMMON NEUROTROPHIN RECEPTOR P75 |
1TNR | R:98-153; R:15-97 | CRYSTAL STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX: IMPLICATIONS FOR TNF RECEPTOR ACTIVATION |
2AW2 | B:58-103; Y:58-103; B:2-57; Y:2-57 | CRYSTAL STRUCTURE OF THE HUMAN BTLA-HVEM COMPLEX |
2H9G | R:62-101; R:21-61 | CRYSTAL STRUCTURE OF PHAGE DERIVED FAB BDF1 WITH HUMAN DEATH RECEPTOR 5 (DR5) |
3BUK | C:83-161; D:83-161; C:3-82; D:3-82 | CRYSTAL STRUCTURE OF THE NEUROTROPHIN-3 AND P75NTR SYMMETRICAL COMPLEX |